关注
Brij Bhushan Mehta
Brij Bhushan Mehta
Researcher, Department of Immunology, Oslo University Hospital
在 medisin.uio.no 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
In silico proof of principle of machine learning-based antibody design at unconstrained scale
R Akbar, PA Robert, CR Weber, M Widrich, R Frank, M Pavlović, ...
MAbs 14 (1), 2031482, 2022
882022
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies
R Akbar, H Bashour, P Rawat, PA Robert, E Smorodina, TS Cotet, ...
MAbs 14 (1), 2008790, 2022
702022
Unconstrained generation of synthetic antibody–antigen structures to guide machine learning methodology for antibody specificity prediction
PA Robert, R Akbar, R Frank, M Pavlović, M Widrich, I Snapkov, ...
Nature Computational Science 2 (12), 845-865, 2022
342022
Individualized VDJ recombination predisposes the available Ig sequence space
A Slabodkin, M Chernigovskaya, I Mikocziova, R Akbar, L Scheffer, ...
Genome Research 31 (12), 2209-2224, 2021
302021
Role of dexamethasone and methylprednisolone corticosteroids in coronavirus disease 2019 hospitalized patients: a review
J Mehta, R Rolta, BB Mehta, N Kaushik, EH Choi, NK Kaushik
Frontiers in Microbiology 13, 813358, 2022
292022
One billion synthetic 3D-antibody-antigen complexes enable unconstrained machine-learning formalized investigation of antibody specificity prediction
PA Robert, R Akbar, R Frank, M Pavlović, M Widrich, I Snapkov, ...
BioRXiV, 2021.07. 06.451258, 2021
252021
Amelioration of collagen antibody induced arthritis in mice by an antibody directed against the fibronectin type III repeats of tenascin-C: Targeting fibronectin type III …
BB Mehta, A Tiwari, S Sharma, A Shukla, M Sharma, RK Vasishta, ...
International immunopharmacology 58, 15-23, 2018
132018
Blocking osteopontin-fibronectin interactions reduce extracellular fibronectin deployment and arthritic immunopathology
BB Mehta, S Sharma, RK Vasishta, RK Sen, A Sharma, ...
International Immunopharmacology 55, 297-305, 2018
102018
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies. mAbs
R Akbar, H Bashour, P Rawat, PA Robert, E Smorodina, TS Cotet, ...
Taylor & Francis, 2022
72022
 Antibacterial activity and phytochemical screening of selected medicinal plants against SalmonellaentericaserovarTyphimurium strains
UMBB Mehta J*, Jandaik S 1
International Journal of Biology, Pharmacy and Allied Sciences (IJBPAS) 5 …, 2016
2*2016
Baselining the Buzz. Trastuzumab-HER2 Affinity, and Beyond!
L Chinery, AM Hummer, BB Mehta, R Akbar, P Rawat, A Slabodkin, ...
bioRxiv, 2024.03. 26.586756, 2024
12024
Targeting catalytic domains of gelatinase A and B using fully human antibody
BB Mehta
Journal of Clinical & Experimental Orthopaedics, 2021
2021
Targeting catalytic domains of Gelatinase A and B using fully human antibody in the context of rheumatoid arthritis
RKSMLG Brij Bhushan Mehta1*, Anil Tiwari1§, Aman Sharma2
9th European Congress on Rheumatology, Autoimmunity and Orthopedics 8, DOI …, 2018
2018
Characterization of a fully human antibody targeting osteopontin in the context of rheumatoid arthritis
BB Mehta, A Sharma, RK Sen, ML Guptasarma
Indian Journal of Rheumatology, S22, 2014
2014
系统目前无法执行此操作,请稍后再试。
文章 1–14